Hookipa Pharma earnings were -$43.4M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest HOOK earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$13.8M, down 27.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, HOOK reported annual earnings of -$81.6M, with 25.7% growth.
On HOOK's earnings call on Invalid Date, Hookipa Pharma (NASDAQ: HOOK) reported Q3 2024 earnings per share (EPS) of -$1.10, up 36.42% year over year. Total HOOK earnings for the quarter were -$13.84 million. In the same quarter last year, Hookipa Pharma's earnings per share (EPS) was -$1.73.
As of the last Hookipa Pharma earnings report, Hookipa Pharma is currently losing money. Hookipa Pharma's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$43.37 million, a 37.21% decrease year over year.
What was HOOK's earnings growth in the past year?
As of Hookipa Pharma's earnings date in Invalid Date, Hookipa Pharma's earnings has grown year over year. HOOK earnings in the past year totalled -$43.37 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.